Clinical Trial Update: Anti-inflammatory Effects of Caffeine in Chronic Obstructive Pulmonary Disease (COPD) Subjects [NA]

View source ↗

Summary

A clinical trial investigating the anti-inflammatory effects of caffeine in chronic obstructive pulmonary disease subjects was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Caffeine (caffeine)

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Chronic Obstructive Pulmonary Disease | NA | Status: WITHDRAWN